Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study

PURPOSE: This phase 2b, randomized, observer-masked, placebo- and active-controlled, parallel-group, multinational (USA and Japan), multicenter study (NCT03216902) assessed the optimal dose of sepetaprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Wirta, David L., Kuwayama, Yasuaki, Lu, Fenghe, Shao, Hui, Odani-Kawabata, Noriko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048176/
https://www.ncbi.nlm.nih.gov/pubmed/35167779
http://dx.doi.org/10.1089/jop.2021.0077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048176/
https://www.ncbi.nlm.nih.gov/pubmed/35167779
http://dx.doi.org/10.1089/jop.2021.0077

Ejemplares similares